Insulin therapy in the elderly with type 2 diabetes
1University of Helsinki, Department of General Practice and Primary Health Careand Helsinki University Hospital, Helsinki, Finland - johan.eriksson@helsinki.fi.
Minerva Endocrinologica
|September 10, 2015
Summary
Insulin therapy, particularly basal insulin analogues, simplifies treatment for elderly patients with type 2 diabetes (T2D). Careful initiation and dose titration are key to managing T2D effectively while minimizing hypoglycemia risks.
Area of Science:
- Geriatric Medicine
- Endocrinology
- Pharmacology
Background:
- Type 2 diabetes (T2D) is a progressive condition often requiring insulin therapy in older adults to achieve treatment goals and enhance quality of life.
- Insulin use in elderly T2D patients is often limited by perceived complexity, despite advancements in delivery systems.
- Basal insulin analogues offer a simplified, once-daily injection regimen suitable for geriatric populations.
Purpose of the Study:
- To review the current understanding and practical application of insulin therapy in elderly patients with type 2 diabetes.
- To discuss the benefits of long-acting insulin analogues in simplifying treatment regimens for older adults.
- To highlight considerations for initiating and adjusting insulin therapy, including basal, prandial, and premixed analogues, while emphasizing hypoglycemia avoidance.
Main Methods:
- Review of literature on insulin therapy in elderly patients with type 2 diabetes.
- Discussion of different insulin types, including basal, prandial, and premixed insulin analogues.
- Consideration of patient cases to illustrate treatment strategies and challenges.
Main Results:
- Long-acting insulin analogues (e.g., detemir, glargine) provide a straightforward, once-daily injection option for elderly T2D patients.
- Initiating basal insulin in combination with oral medications, such as metformin, is a convenient initial regimen.
- The use of newer insulin analogues and strategies involving prandial or premixed insulins can be tailored to individual needs.
Conclusions:
- Insulin therapy, particularly with basal analogues, can be effectively and safely used in elderly patients with T2D.
- A 'start low and go slow' approach is recommended to minimize hypoglycemia and optimize glycemic control.
- Careful consideration of treatment intensification, including multiple daily injections, is necessary for optimal long-term management.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
1.2K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:15Drug Dosing: Geriatric Patients
357
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
357
01:36Carbohydrate Metabolism
15.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.0K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
962
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
962
01:22Diabetes Mellitus: Type 2 and Gestational
5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K